Please sign in to follow a disease.
Retinoblastoma
MONDO:0008380A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. Approximately 95% of cases are diagnosed before age 5. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.
Also known as: RB, retinoblastoma, retinoblastoma, malignant, RB1, Rb, eye cancer, retinoblastoma
2884 clinical trials for this condition and its sub-types, 32 tagged with Retinoblastoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Retinoblastoma
-
Unilateral retinoblastoma 6 trials
-
Intraocular retinoblastoma 4 trials · 5 incl. sub-types
1 sub-type
- Pediatric intraocular retinoblastoma 2 trials
-
Bilateral retinoblastoma 3 trials
-
Extraocular retinoblastoma 2 trials
1 sub-type
- Pediatric extraocular retinoblastoma 0 trials
-
Hereditary retinoblastoma 2 trials
-
Non-hereditary retinoblastoma 0 trials
-
Trilateral retinoblastoma 0 trials
-
Targeted pill shows promise for rare genetic cancers
Disease control CompletedThis study tested an experimental drug called ENV-101 (taladegib) in 20 adults with advanced solid tumors that have a specific genetic mutation (PTCH1 loss-of-function). The drug works by blocking a growth pathway in cancer cells. Researchers measured how many patients' tumors sh…
Phase 2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for kids with retinoblastoma: tailored therapies aim to save lives and sight
Disease control CompletedThis study tested personalized treatments for children with retinoblastoma, a rare eye cancer. Researchers divided 107 participants into groups based on whether one or both eyes were affected and how advanced the cancer was. They used combinations of chemotherapy drugs like vincr…
Phase 3 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:44 UTC
-
Can a simple spit test predict chemo-related deafness in kids?
Knowledge-focused CompletedThis study looked at 119 children who had platinum-based chemotherapy for certain cancers. Researchers wanted to find out if certain genes make some kids more likely to develop hearing loss from the treatment. By analyzing DNA from saliva samples, they hope to identify high-risk …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC